Anixa Biosciences Inc Quarterly Deferred Tax Assets, Gross in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Anixa Biosciences Inc quarterly Deferred Tax Assets, Gross history and growth rate from Q3 2012 to Q3 2024.
  • Anixa Biosciences Inc Deferred Tax Assets, Gross for the quarter ending October 31, 2024 was $37.8B.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $37.8B* +$37.7B Oct 31, 2024 10-K 2025-01-10
Q3 2023 $34.5M +$4.9M +16.6% Oct 31, 2023 10-K 2025-01-10
Q3 2022 $29.6M +$1.32M +4.67% Oct 31, 2022 10-K 2024-01-16
Q3 2021 $28.3M -$475K -1.65% Oct 31, 2021 10-K 2023-01-04
Q3 2020 $28.8M +$396K +1.4% Oct 31, 2020 10-K 2022-01-04
Q3 2019 $28.4M +$1.94M +7.36% Oct 31, 2019 10-K 2021-01-07
Q3 2018 $26.4M +$2.99M +12.8% Oct 31, 2018 10-K 2020-01-09
Q3 2017 $23.4M -$16.9M -41.9% Oct 31, 2017 10-K 2019-01-11
Q3 2016 $40.3M +$1.77M +4.58% Oct 31, 2016 10-K 2018-01-09
Q3 2015 $38.5M +$888K +2.36% Oct 31, 2015 10-K/A 2016-12-08
Q3 2014 $37.7M +$7.78M +26.1% Oct 31, 2014 10-K 2015-12-23
Q3 2013 $29.9M +$2.49M +9.08% Oct 31, 2013 10-K 2015-01-29
Q3 2012 $27.4M Oct 31, 2012 10-K/A 2014-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.